Shinchi Araki

5PUBLICATIONS
4CO-AUTHORS
Molecular medicineMolecular targetsClinical nutritionMajor global burdens of diseaseSport and exercise nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 16, 2024
SGLT2 inhibitors increase low serum magnesium levels in patients with chronic kidney disease immediately after treatment.

Kosuke Osawa, Masaki Ohya, Shuto Yamamoto

|Jun 21, 2020
Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients.

Atsunori Kashiwagi, Shinchi Araki, Hiroshi Maegawa

|Sep 15, 2019
Combined effect of sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors for diabetic kidney disease.

Shin-Ichi Araki

|Nov 20, 2018
Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014.

Shinji Kume, Shin-Ichi Araki, Satoshi Ugi

|Oct 26, 2017
Impact of obesity on annual medical expenditures and diabetes care in Japanese patients with type 2 diabetes mellitus.

Chisato Kusunoki-Tsuji, Shin-Ichi Araki, Shinji Kume

Pageof 1

Frequent Collaborators

1 joint publications

Shinji Kume

1 joint publications

Katsutaro Morino

1 joint publications

Atsunori Kashiwagi

1 joint publications

Hiroshi Maegawa